Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. 2005

Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Uppsalalaan 8, 3584CT Utrecht, The Netherlands.

The self-renewing epithelium of the small intestine is ordered into stem/progenitor crypt compartments and differentiated villus compartments. Recent evidence indicates that the Wnt cascade is the dominant force in controlling cell fate along the crypt-villus axis. Here we show a rapid, massive conversion of proliferative crypt cells into post-mitotic goblet cells after conditional removal of the common Notch pathway transcription factor CSL/RBP-J. We obtained a similar phenotype by blocking the Notch cascade with a gamma-secretase inhibitor. The inhibitor also induced goblet cell differentiation in adenomas in mice carrying a mutation of the Apc tumour suppressor gene. Thus, maintenance of undifferentiated, proliferative cells in crypts and adenomas requires the concerted activation of the Notch and Wnt cascades. Our data indicate that gamma-secretase inhibitors, developed for Alzheimer's disease, might be of therapeutic benefit in colorectal neoplastic disease.

UI MeSH Term Description Entries
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.

Related Publications

Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
August 2016, Nature reviews. Gastroenterology & hepatology,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
May 2020, Clinical cancer research : an official journal of the American Association for Cancer Research,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
March 2013, Anticancer research,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
January 2009, Nature medicine,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
January 2013, OncoTargets and therapy,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
August 2008, Oncogene,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
August 2002, Biochemical Society transactions,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
November 2004, Toxicological sciences : an official journal of the Society of Toxicology,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
February 2008, Journal of the neurological sciences,
Johan H van Es, and Marielle E van Gijn, and Orbicia Riccio, and Maaike van den Born, and Marc Vooijs, and Harry Begthel, and Miranda Cozijnsen, and Sylvie Robine, and Doug J Winton, and Freddy Radtke, and Hans Clevers
March 2007, Cancer research,
Copied contents to your clipboard!